Posts

Fluoroquinolones Safety Concerns and Warnings (Part I) – Blog Post by Asrar Qureshi

Image
Dear Colleagues!  Today is Pharma Veterans Blog Post #173. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to recognize and celebrate the Pharma Industry Professionals.  Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  If you wish to share your stories, ideas and thoughts, please email to asrar@asrarqureshi.com for publishing your contributions here . FLUOROQUINOLONES Fluoroquinolones class of drugs was introduced in 1980s. Quinolones such as nalidixic acid (Negram®) had been available much before that. Later pipemidic acid (Urixin®) was added. The first major fluoroquinolone was norfloxacin (Noroxin®). A battery of fluoroquinolones was then introduced on the world market in quick succession. Pakistan also boasts a large market share captured by quinolones. Almost all products from this category have sold very well in Pakistan market, some mor...

STEM CELL TREATMENT (Part III) – Blog Post by Hasan Jamal

Dear Colleagues!  Today is Pharma Veterans Blog Post #172. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to recognize and celebrate the Pharma Industry Professionals.  Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  If you wish to share your stories, ideas and thoughts, please email to asrar@asrarqureshi.com for publishing your contributions here . Continued from previous…… ·       The best way to try stem cell treatment If you want to look into stem cell treatment, experts say the best way is to ask your doctor whether any reputable medical centers are conducting clinical trials focused on your disease. You can find trials at the National Institutes of Health’s website clinicaltrials.gov , but there is another caveat: “Some clinics say they are doing a ‘patient-funded study,’ and they’ll even lis...